Maternal-Fetal Medicine  ·  Clinical Discussion

Mirror Syndrome

Ballantyne Syndrome: A Triad of Maternal, Fetal, and Placental Edema

Dr. C. Onyeije, MFM First described 1892 Rare · Life-Threatening
Definition

What Is Mirror Syndrome?

🤰
Mother
Systemic edema, hemodilution, hypertension
🫀
Placenta
Massive placentomegaly with fluid collection
👶
Fetus
Hydrops fetalis — ≥2 body cavity effusions

Maternal fluid retention "mirrors" fetal hydrops — hence the name. First described by Ballantyne in 1892.

Pathophysiology

How It Develops

Severe
Fetal Hydrops
Placentomegaly
+ Edema
Anti-angiogenic
Factor Release
Endothelial
Dysfunction
Massive Maternal
Fluid Shifts

Placental hyperplacentosis drives elevated hCG and release of vasoactive mediators, producing systemic maternal edema.

Epidemiology

How Common?

~29%
of severe fetal hydrops pregnancies
22–28 wks
Mean gestational age at onset
67.2%
Fetal mortality rate
Rare
Exact incidence unknown
Etiology

Underlying Causes of Fetal Hydrops

Rh Isoimmunization
29%
Twin-Twin Transfusion Syndrome (TTTS)
18%
Parvovirus B19
16%
Structural Anomalies (Ebstein, SCT)
Other

Any cause of immune or non-immune hydrops may trigger Mirror syndrome.

Clinical Presentation

Maternal Signs & Symptoms

🤰
  • 62.2% Maternal edema (face, limbs, generalized)
  • 54.9% Hypoalbuminemia
  • 39.0% Anemia — secondary to hemodilution
  • 39.0% New-onset hypertension
  • Elevated Serum hCG (hyperplacentosis)
  • Variable Headache, visual disturbances, elevated LFTs
Fetal & Placental Findings

Fetal & Placental Findings

👶
Fetal Hydrops
≥2 body cavity effusions
Mean onset: 29 weeks (vs. 31 wks in non-mirror hydrops)
📊
Edema Severity
Fetal edema-to-BPD ratio:
0.23 (Mirror) vs. 0.16 (non-mirror)
🫁
Pleural / Ascites
Bilateral pleural effusions, ascites, skin edema, pericardial effusion
🟥
Placentomegaly
Massive placental edema with fluid collection — a hallmark finding
Differential Diagnosis

Mirror Syndrome vs. Severe Preeclampsia

Parameter Mirror Syndrome Severe Preeclampsia
Hemodynamics Hemodilution ↓ Hct Hemoconcentration ↑ Hct
Oncotic Pressure Severe hypoalbuminemia Mild–moderate decrease
Fetal Status Always severe hydrops IUGR or normal
Placenta Placentomegaly + edema Infarctions / insufficiency
Uric Acid Normal–mildly elevated Severely elevated
Diagnostic Hallmark

The Key Distinguishing Feature

HEMODILUTION
↓ Hct  ·  ↓ Albumin
Mirror Syndrome
Anemia from fluid overload
HEMOCONCENTRATION
↑ Hct  ·  ↑ Uric Acid
Severe Preeclampsia
Volume depletion

Always evaluate for fetal hydrops when maternal edema is atypical or does not fit classic preeclampsia.

Management

Management Framework

1. Confirm diagnosis: fetal hydrops + maternal edema triad
2. Determine etiology of fetal hydrops (Rh, TTTS, Parvo B19, structural)
3. Maternal stabilization — ICU-level hemodynamic monitoring
Is the hydrops etiology reversible in utero?
YES →
Fetal therapy
(IUT, fetoscopic laser, cardiac Rx)
NO →
Delivery or pregnancy termination
regardless of gestational age
Fetal Therapy

In-Utero Fetal Therapy Options

🩸
Intrauterine Transfusion
Parvovirus B19
Rh alloimmunization
🔬
Fetoscopic Laser Ablation
Twin-Twin Transfusion Syndrome (TTTS)
💊
Fetal Cardiac Therapy
Arrhythmia-driven hydrops
Transplacental antiarrhythmics

Successful fetal therapy → reliable resolution of maternal symptoms

Delivery Indications

When to Deliver

Maternal safety strictly dictates the timeline for intervention — regardless of gestational age.

Patient Counseling

Counseling the Patient

What is this?
Your body is retaining fluid as a direct response to your baby's severely swollen condition and placenta.
Why does it matter?
The fluid overload threatens your heart and lungs. Your safety is the absolute priority.
What is the prognosis?
Fetal mortality is high — up to 67%. Survival depends entirely on whether the cause of fetal swelling can be reversed.
What happens next?
Treatment of the fetus, or delivery, will halt the disease process. Your symptoms will resolve over several days.
Maternal Outcomes

Maternal Prognosis

After Delivery or Hydrops Resolution
Maternal symptoms reliably regress. Edema, hypertension, and hemodilution normalize over days.
⚠️
Acute Risks
Pulmonary edema, cardiac decompensation — requires ICU-level or high-acuity obstetric monitoring.
🏥
Level of Care
High-acuity obstetric unit or ICU. Parallel maternal and fetal assessment required.
📉
Maternal Mortality
Rare with prompt recognition and management. Delay in diagnosis increases risk.
Summary

Clinical Takeaways

  1. 1Mirror syndrome = maternal + fetal + placental edema triad — a life-threatening obstetric emergency
  2. 2Distinguish from preeclampsia: hemodilution (↓ Hct, ↓ albumin) is the diagnostic key
  3. 3Fetal mortality up to 67.2% — etiology of hydrops drives prognosis and management
  4. 4Successful fetal therapy can resolve maternal disease — always evaluate reversibility
  5. 5Delivery is definitive treatment; maternal symptoms reliably resolve after intervention
References

Key References

← OpenMFM Library